A carregar...

Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review

BACKGROUND: In patients with hormone receptor-positive breast cancer, differentiating between patients with a low and a high risk of recurrence is an ongoing challenge. In current practice, prognostic clinical parameters are used for risk prediction. DNA methylation markers have been proven to be of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res
Main Authors: de Ruijter, Tim C., van der Heide, Frank, Smits, Kim M., Aarts, Maureen J., van Engeland, Manon, Heijnen, Vivianne C. G.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6993426/
https://ncbi.nlm.nih.gov/pubmed/32005275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-020-1250-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!